• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Kodak acquires CAD technology

Article

As part of an increasingly aggressive strategy to focus on digital imaging, Eastman Kodak has acquired software firm MiraMedica and its computer-aided detection technology. The price paid for the privately held Los Gatos, CA, company was not disclosed.

As part of an increasingly aggressive strategy to focus on digital imaging, Eastman Kodak has acquired software firm MiraMedica and its computer-aided detection technology. The price paid for the privately held Los Gatos, CA, company was not disclosed. Kodak is picking up several key employees as part of the deal. MiraMedica's chief technology officer, Wido Menhardt, will become general manager of CAD operations. Company president and CEO Caren Mason will serve as a business consultant during the transition of CAD operations to Kodak. The CAD software, which was the target of the acquisition, automatically highlights suspicious areas on images either acquired digitally or digitized from film. It will be sold as a stand-alone product and as a component of Kodak digital capture and image and information management systems. The CAD technology is built on a platform licensed exclusively from Lockheed Martin Space Systems and the University of South Florida.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.